Therefore, to determine the impact of iBAP-II on SCLC cell viability, we treated four different BAP1-WT SCLC cell lines (NCI-H1963, NCI-H748, NCI-H1882, and KP3 cells) with either DMSO, iBAP, or iBAP-II. The gene discussed is BAP1; the disease is small cell lung carcinoma.